Site-specific interaction of the antitumor antibiotic dynemicin with branched DNA molecules.
Identifieur interne : 002825 ( PubMed/Checkpoint ); précédent : 002824; suivant : 002826Site-specific interaction of the antitumor antibiotic dynemicin with branched DNA molecules.
Auteurs : M. Lu [États-Unis] ; Q. Guo ; N R KallenbachSource :
- Journal of biomolecular structure & dynamics [ 0739-1102 ] ; 1991.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical , chemistry : Anthraquinones, Antibiotics, Antineoplastic, DNA.
- chemical , metabolism : Anthraquinones, Antibiotics, Antineoplastic, DNA.
- Base Sequence, Binding Sites, Enediynes, Molecular Sequence Data, Molecular Structure.
Abstract
A specific interaction of stable branched DNA molecules with the antitumor antibiotic dynemicin is reported. Dynemicin contains an anthraquinone and an enediyne unit, and belongs to the family of enediyne antitumor agents. DNA strand scission by dynemicin appears to involve interaction of the anthraquinone core with DNA and release of a phenyl diradical from the enediyne core that can abstract hydrogen atoms from the sugar phosphate backbone of DNA. The cleavage patterns of each labeled strand in two branched tetramers of four 16-mers are compared with those of the same strands in unbranched duplex controls. Differences between the profiles corresponding to scission of branched and duplex DNA molecules can be detected in most of the strands. The strongest differences define a specific site flanking the branch in each of two branched structures. At 18 degrees C, cleavage at strand positions demarcating the site of enhanced affinity in both junctions is observed to be 70-100% more efficient than at the corresponding sequence positions in the control duplex DNA molecules. The patterns of preferential cleavage at these sites are significantly altered in the presence of excess propidium diiodide, an intercalative drug.
DOI: 10.1080/07391102.1991.10507912
PubMed: 1741963
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:1741963Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Site-specific interaction of the antitumor antibiotic dynemicin with branched DNA molecules.</title>
<author><name sortKey="Lu, M" sort="Lu, M" uniqKey="Lu M" first="M" last="Lu">M. Lu</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Chemistry, New York University, NY 10003.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Chemistry, New York University</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guo, Q" sort="Guo, Q" uniqKey="Guo Q" first="Q" last="Guo">Q. Guo</name>
</author>
<author><name sortKey="Kallenbach, N R" sort="Kallenbach, N R" uniqKey="Kallenbach N" first="N R" last="Kallenbach">N R Kallenbach</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1741963</idno>
<idno type="pmid">1741963</idno>
<idno type="doi">10.1080/07391102.1991.10507912</idno>
<idno type="wicri:Area/PubMed/Corpus">002983</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002983</idno>
<idno type="wicri:Area/PubMed/Curation">002983</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002983</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002825</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002825</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Site-specific interaction of the antitumor antibiotic dynemicin with branched DNA molecules.</title>
<author><name sortKey="Lu, M" sort="Lu, M" uniqKey="Lu M" first="M" last="Lu">M. Lu</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Chemistry, New York University, NY 10003.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Chemistry, New York University</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guo, Q" sort="Guo, Q" uniqKey="Guo Q" first="Q" last="Guo">Q. Guo</name>
</author>
<author><name sortKey="Kallenbach, N R" sort="Kallenbach, N R" uniqKey="Kallenbach N" first="N R" last="Kallenbach">N R Kallenbach</name>
</author>
</analytic>
<series><title level="j">Journal of biomolecular structure & dynamics</title>
<idno type="ISSN">0739-1102</idno>
<imprint><date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anthraquinones (chemistry)</term>
<term>Anthraquinones (metabolism)</term>
<term>Antibiotics, Antineoplastic (chemistry)</term>
<term>Antibiotics, Antineoplastic (metabolism)</term>
<term>Base Sequence</term>
<term>Binding Sites</term>
<term>DNA (chemistry)</term>
<term>DNA (metabolism)</term>
<term>Enediynes</term>
<term>Molecular Sequence Data</term>
<term>Molecular Structure</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ADN ()</term>
<term>ADN (métabolisme)</term>
<term>Anthraquinones ()</term>
<term>Anthraquinones (métabolisme)</term>
<term>Antibiotiques antinéoplasiques ()</term>
<term>Antibiotiques antinéoplasiques (métabolisme)</term>
<term>Données de séquences moléculaires</term>
<term>Sites de fixation</term>
<term>Structure moléculaire</term>
<term>Séquence nucléotidique</term>
<term>Ènediynes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Anthraquinones</term>
<term>Antibiotics, Antineoplastic</term>
<term>DNA</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Anthraquinones</term>
<term>Antibiotics, Antineoplastic</term>
<term>DNA</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>ADN</term>
<term>Anthraquinones</term>
<term>Antibiotiques antinéoplasiques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Base Sequence</term>
<term>Binding Sites</term>
<term>Enediynes</term>
<term>Molecular Sequence Data</term>
<term>Molecular Structure</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>ADN</term>
<term>Anthraquinones</term>
<term>Antibiotiques antinéoplasiques</term>
<term>Données de séquences moléculaires</term>
<term>Sites de fixation</term>
<term>Structure moléculaire</term>
<term>Séquence nucléotidique</term>
<term>Ènediynes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A specific interaction of stable branched DNA molecules with the antitumor antibiotic dynemicin is reported. Dynemicin contains an anthraquinone and an enediyne unit, and belongs to the family of enediyne antitumor agents. DNA strand scission by dynemicin appears to involve interaction of the anthraquinone core with DNA and release of a phenyl diradical from the enediyne core that can abstract hydrogen atoms from the sugar phosphate backbone of DNA. The cleavage patterns of each labeled strand in two branched tetramers of four 16-mers are compared with those of the same strands in unbranched duplex controls. Differences between the profiles corresponding to scission of branched and duplex DNA molecules can be detected in most of the strands. The strongest differences define a specific site flanking the branch in each of two branched structures. At 18 degrees C, cleavage at strand positions demarcating the site of enhanced affinity in both junctions is observed to be 70-100% more efficient than at the corresponding sequence positions in the control duplex DNA molecules. The patterns of preferential cleavage at these sites are significantly altered in the presence of excess propidium diiodide, an intercalative drug.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1741963</PMID>
<DateCompleted><Year>1992</Year>
<Month>01</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>11</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0739-1102</ISSN>
<JournalIssue CitedMedium="Print"><Volume>9</Volume>
<Issue>2</Issue>
<PubDate><Year>1991</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of biomolecular structure & dynamics</Title>
<ISOAbbreviation>J. Biomol. Struct. Dyn.</ISOAbbreviation>
</Journal>
<ArticleTitle>Site-specific interaction of the antitumor antibiotic dynemicin with branched DNA molecules.</ArticleTitle>
<Pagination><MedlinePgn>271-83</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A specific interaction of stable branched DNA molecules with the antitumor antibiotic dynemicin is reported. Dynemicin contains an anthraquinone and an enediyne unit, and belongs to the family of enediyne antitumor agents. DNA strand scission by dynemicin appears to involve interaction of the anthraquinone core with DNA and release of a phenyl diradical from the enediyne core that can abstract hydrogen atoms from the sugar phosphate backbone of DNA. The cleavage patterns of each labeled strand in two branched tetramers of four 16-mers are compared with those of the same strands in unbranched duplex controls. Differences between the profiles corresponding to scission of branched and duplex DNA molecules can be detected in most of the strands. The strongest differences define a specific site flanking the branch in each of two branched structures. At 18 degrees C, cleavage at strand positions demarcating the site of enhanced affinity in both junctions is observed to be 70-100% more efficient than at the corresponding sequence positions in the control duplex DNA molecules. The patterns of preferential cleavage at these sites are significantly altered in the presence of excess propidium diiodide, an intercalative drug.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Chemistry, New York University, NY 10003.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guo</LastName>
<ForeName>Q</ForeName>
<Initials>Q</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kallenbach</LastName>
<ForeName>N R</ForeName>
<Initials>NR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>CA-24101</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Biomol Struct Dyn</MedlineTA>
<NlmUniqueID>8404176</NlmUniqueID>
<ISSNLinking>0739-1102</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000880">Anthraquinones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000903">Antibiotics, Antineoplastic</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053281">Enediynes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance UI="D004247">DNA</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>D3G8N2863A</RegistryNumber>
<NameOfSubstance UI="C061229">dynemicin A</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000880" MajorTopicYN="N">Anthraquinones</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000903" MajorTopicYN="N">Antibiotics, Antineoplastic</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053281" MajorTopicYN="N">Enediynes</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year>
<Month>10</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1991</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1991</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">1741963</ArticleId>
<ArticleId IdType="doi">10.1080/07391102.1991.10507912</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>État de New York</li>
</region>
</list>
<tree><noCountry><name sortKey="Guo, Q" sort="Guo, Q" uniqKey="Guo Q" first="Q" last="Guo">Q. Guo</name>
<name sortKey="Kallenbach, N R" sort="Kallenbach, N R" uniqKey="Kallenbach N" first="N R" last="Kallenbach">N R Kallenbach</name>
</noCountry>
<country name="États-Unis"><region name="État de New York"><name sortKey="Lu, M" sort="Lu, M" uniqKey="Lu M" first="M" last="Lu">M. Lu</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002825 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002825 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:1741963 |texte= Site-specific interaction of the antitumor antibiotic dynemicin with branched DNA molecules. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:1741963" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |